Data Bridge Market Research analyzes that the next generation sequencing (NGS) market, which was USD 7,008.17 million in 2022, is likely to reach USD 31,417.25 million by 2030 and is expected to undergo a CAGR of 17.1% during the forecast period. “Instruments” dominates the product segment of the next generation sequencing (NGS) market due to the growing demand for NGS.
The global Next Generation Sequencing (NGS) Market research report 2030, as published by Data bridge Market Research, provides insights into the current global outlook and key regions, examining Major Players, Countries, Product Types, and end industries. It focuses on top players in the global market and categorizes the market based on several parameters.
This Next Generation Sequencing (NGS) market research report identifies the competitive landscape of industries, offering a comprehensive understanding of international competition. The study outlines the anticipated growth of the global market during forecast period. Compiled with a blend of static and dynamic perspectives, this research report captures the essence of the businesses views.
Top Companies in the Global Next Generation Sequencing (NGS) Market:
Agilent Technologies, Inc.(U.S.), ThermoFisher Scientific, Inc.(U.S.), QIAGEN (Netherlands), Illumina, Inc.(U.S.), Bio-Rad Laboratories, Inc. (U.S.), Roche Sequencing (A subsidiary of F. Hoffman La Roche) (Switzerland), BGI (A subsidiary of BGI Group) (China), Oxford Nanopore Technologies plc (U.K.), MACROGEN CO., LTD.(South Korea), DNASTAR (U.S.), Geneious, Partek , Incorporated (U.S.), PerkinElmer Inc.(U.S.), Takara Bio Inc. (Japan), bioMérieux SA (France), Pacific Biosciences of California, Inc.(U.S.), GENEWIZ (U.S.), 10x Genomics (U.S.), New England Biolabs (U.S.), Hamilton Company (U.S.), among others.
Get Sample PDF Copy of Report:
Market Segmentation:
The next generation sequencing (NGS) market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
• Instruments
• Consumables
• Services
Application
• Diagnostics
• Biomarker Discovery
• Precision Medicine
• Drug Discovery
• Agriculture and Animal Research
• Others
End User
• Pharmaceutical & Biotechnology Companies
• Research Centers & Academic Government Institutes
• Hospital & Clinics
Geographically, the detailed analysis of consumption, revenue, market share, and growth rate of the following regions:
– Middle East and Africa (South Africa, Saudi Arabia, UAE, Israel, Egypt, etc.)
– North America (United States, Mexico & Canada)
– South America (Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, etc.)
– Europe (Turkey, Spain, Turkey, Netherlands Denmark, Belgium, Switzerland, Germany, Russia UK, Italy, France, etc.)
– Asia-Pacific (Taiwan, Hong Kong, Singapore, Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia).
Market Dynamics:
Drivers
• Advancements in sequencing technologies
Technological improvements have significantly increased the speed at which DNA and RNA sequences can be determined. Next-generation sequencing platforms can now process a larger number of samples simultaneously, leading to higher throughput. This is particularly valuable in research and clinical applications where large-scale sequencing is required, such as in genomics studies and diagnostic testing. Continuous innovations in NGS platforms have led to improved speed, accuracy, and cost-efficiency. These advancements make NGS more accessible and attractive to researchers and healthcare professionals.
• Awareness of precision medicine
In oncology, precision medicine is a rapidly growing field. NGS is used to analyze the genomic alterations in cancer cells, which can help identify potential targets for treatment and predict the response to specific therapies. The increasing awareness of targeted therapies for cancer treatment drives the demand for NGS. Growing awareness of the potential of NGS for personalized medicine has boosted its adoption. NGS enables the development of treatment strategies tailored to an individual's genetic profile, which is seen as a key component of the future of healthcare.
Opportunity
• Integration of Multi-Omics Data
The integration of genomics, transcriptomics, epigenomics, and metagenomics data using NGS provides comprehensive insights into complex biological systems. This opportunity supports a deeper understanding of health and disease. Advances in NGS technologies enable the integration of multiple omics data, including genomics, transcriptomics, epigenomics, and metagenomics. Researchers can gain a more comprehensive view of biological systems, leading to better insights and discoveries.
Browse The Report Description:
https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market
Strategic Points from Table of Content:
– Market Summary
– Economic Impact Competition Analysis by Players
– Production, Revenue (Value) by geographical segmentation
– Next Generation Sequencing (NGS) Market Size by Type and Application
– Regional Market Status and Outlook
– Next Generation Sequencing (NGS) Market Analysis and Outlook
– Next Generation Sequencing (NGS) Market Forecast by Region, Type, and Application
– Cost Investigation, Market Dynamics
– Marketing Strategy comprehension, Distributors and Traders
– Market Effect Factor Analysis
– Research Finding/ Conclusion
– Appendix
Browse Other Trending Reports:
Global Meditation Market – Industry Trends and Forecast to 2030
https://www.databridgemarketresearch.com/reports/global-meditation-market
Global Asset Integrity Management Market - Industry Trends and Forecast to 2029
https://www.databridgemarketresearch.com/reports/global-asset-integrity-management-market
Global Additive Manufacturing Market – Industry Trends and Forecast to 2030
https://www.databridgemarketresearch.com/reports/global-additive-manufacturing-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact Us:
Data Bridge Market Research
Tel: +1-888-389.80-2818 | +44 208 089 1725 | +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
